Other studies also show that PIAS3 is overexpressed in GBM samples, while the expression of PIAS1 is downregulated, showing both, as well as other SUMO-related genes, such as RANBP2, single nucleotide variant (SNV) mutations [162] that are also observed in OSCC [170]. The gene discussed is PIAS3; the disease is glioblastoma.